Loading...
OTCM
IGRMF
Market cap34mUSD
, Last price  
USD
Name

Integrum AB

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.16%
Rev. gr., 5y
27.78%
Revenues
91m
-12.50%
18,998,30514,831,00012,265,00017,811,30815,173,77922,449,89726,745,92643,092,56255,723,66274,272,277104,118,63391,100,000
Net income
-31m
L
1,718,463176204-5,745,759-18,358,011-24,583,758-15,685,697-2,140,53621,272,345-16,181,5664,032,478-30,852,000
CFO
-38m
L+195.82%
0-663,000-2,739,000-3,013,507-17,453,535-25,277,747-18,721,094-5,762,529-20,279,782-25,097,950-12,744,220-37,700,000

Profile

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.
URL
https://integrum.se/
IPO date
May 15, 2017
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑042024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑04
Income
Revenues
91,100
-12.50%
104,119
40.19%
74,272
33.29%
Cost of revenue
15,718
12,857
15,870
Unusual Expense (Income)
NOPBT
75,382
91,262
58,402
NOPBT Margin
82.75%
87.65%
78.63%
Operating Taxes
(11,664)
2,004
(5,342)
Tax Rate
2.20%
NOPAT
87,046
89,258
63,744
Net income
(30,852)
-865.09%
4,032
-124.92%
(16,182)
-176.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
74,866
843
3,946
BB yield
-25.69%
-0.08%
-0.82%
Debt
Debt current
1,673
1,580
1,491
Long-term debt
8,015
11,269
14,339
Deferred revenue
Other long-term liabilities
(1)
Net debt
(29,911)
(4,052)
(34,556)
Cash flow
Cash from operating activities
(37,700)
(12,744)
(25,098)
CAPEX
(12,887)
(11,402)
Cash from investing activities
(12,887)
(11,627)
(11,402)
Cash from financing activities
73,286
(649)
3,077
FCF
94,919
75,547
86,665
Balance
Cash
39,599
16,901
41,921
Long term investments
8,466
Excess cash
35,044
11,695
46,673
Stockholders' equity
(64,817)
(34,168)
105,331
Invested Capital
247,536
183,378
104,774
ROIC
40.40%
61.95%
41.47%
ROCE
41.26%
61.16%
38.56%
EV
Common stock shares outstanding
21,334
19,279
18,322
Price
13.66
-76.12%
57.20
118.74%
26.15
-37.74%
Market cap
291,427
-73.57%
1,102,759
130.16%
479,125
-37.22%
EV
261,516
1,098,707
594,774
EBITDA
75,382
93,428
59,557
EV/EBITDA
3.47
11.76
9.99
Interest
479
560
10
Interest/NOPBT
0.64%
0.61%
0.02%